Ansell Limited (ANSLF)
OTCMKTS · Delayed Price · Currency is USD
20.50
+2.50 (13.89%)
At close: Aug 19, 2025
Ansell Market Cap
Ansell has a market cap or net worth of $3.25 billion as of September 12, 2025. Its market cap has increased by 7.88% in one year.
Market Cap
3.25B
Enterprise Value
3.84B
Revenue
2.00B
Ranking
n/a
PE Ratio
31.95
Stock Price
$20.50
Market Cap Chart
Since January 16, 1992, Ansell's market cap has decreased from 3.71B to 3.25B, a decrease of -12.41%. That is a compound annual growth rate of -0.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 3.25B | 7.21% |
| Dec 31, 2024 | 3.03B | 42.26% |
| Dec 29, 2023 | 2.13B | -11.82% |
| Dec 30, 2022 | 2.41B | -17.04% |
| Dec 31, 2021 | 2.91B | -15.63% |
| Dec 31, 2020 | 3.45B | 29.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 358.38M |
| American Oncology Network | 353.52M |